Clinical Efficacy and Mechanism Exploration of MR-61 in Delaying the Progression of Myopia

NCT07298824 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

164

Enrollment

OTHER

Sponsor class

Conditions

Myopia Progressing

Interventions

BIOLOGICAL: Investigational Bifidobacterium Preparation MR-61
OTHER: Placebo for MR-61

Sponsor

Second Affiliated Hospital of Nanchang University